Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Anthera
Biotech
AzurRx brings on longtime drug developer James Pennington as CMO
James Pennington joined AzurRx BioPharma as CMO as the company aims to launch a phase 2 trial of its lead candidate in cystic fibrosis this year.
Conor Hale
May 30, 2018 10:59am
Anthera’s Sollpura canned after phase 3 flop, shares plunge
Mar 12, 2018 9:29am
Anthera loses 64% of its value as CF candidate flunks phase 3 test
Dec 28, 2016 9:40am
